data_1eza_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eza _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.601 . . . . 4.0700000000000003 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mt -73.98 100.98 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.297 -1.001 . . . . 1.5 108.297 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.0 m -95.22 120.01 34.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.112 -0.992 . . . . 1.8 108.713 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.91 -152.9 24.13 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.11 -1.996 . . . . 0.92000000000000004 108.11 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CD1' ' O ' ' A' ' 184' ' ' GLY . 31.4 mt -102.06 -2.09 9.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.973 1.368 . . . . 1.5 111.719 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tp 55.12 101.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.178 -1.009 . . . . 1.3999999999999999 110.856 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -37.87 14.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.639 -0.824 . . . . 1.26 111.704 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -148.91 142.44 16.11 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 107.701 -1.222 . . . . 1.95 107.701 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.68 141.09 15.22 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.588 2.192 . . . . 0.93999999999999995 112.695 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.63 170.93 23.01 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.189 -1.564 . . . . 0.78000000000000003 109.189 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.3 135.55 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 1.29 108.288 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.32 148.87 38.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 1.1499999999999999 109.249 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.6 m-85 -116.48 136.61 52.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.027 -1.101 . . . . 0.71999999999999997 108.027 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.53 161.93 30.27 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 118.834 -1.651 . . . . 0.5 109.603 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -75.45 158.05 33.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.721 -0.87 . . . . 2.3599999999999999 109.288 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.56 123.82 29.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.234 -0.916 . . . . 1.1599999999999999 109.463 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.18 95.19 5.8 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 106.269 -1.752 . . . . 1.24 106.269 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.62 137.92 34.36 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.182 -1.044 . . . . 1.3100000000000001 108.182 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.3 mt -103.2 106.92 17.55 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 107.869 -1.16 . . . . 1.3100000000000001 107.869 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -100.45 137.95 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.12 -1.067 . . . . 2.3500000000000001 108.12 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -129.32 144.92 51.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 2.5800000000000001 109.371 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.38 132.81 35.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.278 -1.008 . . . . 2.1400000000000001 108.278 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.44 146.06 54.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 109.18 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.92 130.83 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.364 -0.835 . . . . 1.28 108.871 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.26 124.0 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.315 -0.994 . . . . 1.3700000000000001 108.315 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.5 mt -91.37 135.95 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.305 -0.872 . . . . 1.3300000000000001 108.859 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -90.98 123.54 34.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 1.3700000000000001 108.639 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -99.09 25.45 6.75 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.025 0.917 . . . . 3.1899999999999999 111.345 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -77.55 140.97 39.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 2.8100000000000001 109.509 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -84.94 128.5 34.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 2.8300000000000001 108.007 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.29 171.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 1.3400000000000001 109.813 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 34' ' ' ASP . 99.2 p -100.86 166.46 10.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 1.3500000000000001 109.254 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.58 -5.01 0.74 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.073 -1.017 . . . . 1.6100000000000001 111.808 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 32' ' ' SER . 2.2 m-20 -80.9 -36.95 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.733 -0.604 . . . . 2.4700000000000002 110.61 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.6 -8.15 35.75 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.326 1.06 . . . . 2.0699999999999998 111.634 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.62 -51.58 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 119.161 -1.016 . . . . 1.3300000000000001 110.455 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -52.57 -35.48 53.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.428 -0.795 . . . . 1.46 110.873 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.58 -40.02 84.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.106 -0.996 . . . . 2.9399999999999999 110.981 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.93 -38.49 86.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.68 -1.263 . . . . 1.3 110.389 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.99 -40.05 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.385 -0.822 . . . . 1.3300000000000001 110.315 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -65.13 -42.37 93.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 1.5 110.252 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -66.65 -32.1 73.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 3.1499999999999999 110.425 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -83.48 -48.46 10.27 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.289 -0.882 . . . . 0.92000000000000004 110.682 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.79 -50.04 68.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.255 -0.978 . . . . 1.4099999999999999 109.123 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -70.06 -31.81 69.6 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 122.241 1.02 . . . . 1.22 109.023 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.49 -49.79 74.69 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.416 -1.474 . . . . 0.58999999999999997 109.416 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' NH2' ' CD ' ' A' ' 86' ' ' GLU . 17.9 ttp180 -58.96 -27.03 64.96 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.187 -1.184 . . . . 3.3900000000000001 110.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -37.9 78.17 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.992 0.901 . . . . 1.26 110.107 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -83.43 -49.67 9.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.634 -0.666 . . . . 2.9900000000000002 110.753 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.32 73.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.427 -0.909 . . . . 1.1399999999999999 109.848 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -62.12 -40.13 94.87 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.326 1.06 . . . . 1.8400000000000001 109.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.56 -39.16 74.12 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.636 -0.711 . . . . 1.22 109.832 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.87 -61.72 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.943 . . . . 2.0 110.393 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.47 -38.07 63.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 1.99 110.243 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -58.18 -39.44 78.9 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 1.27 110.62 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.0 m -67.77 -47.77 68.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 1.24 110.436 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.6 -39.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 1.21 110.438 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -45.61 -47.96 14.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 1.53 111.341 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -70.15 -28.69 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.297 -0.877 . . . . 1.24 110.407 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' OG1' ' A' ' 64' ' ' THR . 81.8 mttt -69.13 -27.46 65.59 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.463 1.125 . . . . 2.3199999999999998 110.178 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.56 52.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.604 0.716 . . . . 1.1699999999999999 109.68 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.47 -30.42 24.66 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.977 -1.106 . . . . 0.57999999999999996 110.557 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.28 -19.3 31.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.06 -1.259 . . . . 1.3899999999999999 111.209 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 25.4 m -93.62 -46.79 7.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.914 -0.584 . . . . 1.3600000000000001 111.03 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.04 -24.98 11.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.329 -0.857 . . . . 1.1399999999999999 112.724 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.47 165.05 12.68 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.25 -0.906 . . . . 0.59999999999999998 112.06 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -54.72 -11.2 0.55 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.762 -0.846 . . . . 2.5899999999999999 112.734 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.68 -37.04 85.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 2.2000000000000002 111.335 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -89.97 -17.62 27.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.822 -1.174 . . . . 2.3599999999999999 112.434 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.13 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 1.54 110.452 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.69 78.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 1.24 110.814 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.81 -41.87 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.374 -0.93 . . . . 1.24 110.078 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -75.13 -25.8 58.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.309 1.052 . . . . 0.80000000000000004 109.957 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -67.16 -35.03 78.81 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.726 0.774 . . . . 1.23 109.95 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.82 -37.48 66.01 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.259 -1.136 . . . . 0.56000000000000005 110.259 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -58.82 -49.57 77.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -1.097 . . . . 2.0600000000000001 110.547 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.3 mt -58.41 -36.41 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 1.24 110.13 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 ttt -58.87 -41.66 87.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 2.4500000000000002 109.954 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.23 -53.39 58.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 1.21 110.555 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.6 tp -56.36 -39.73 73.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.725 -0.61 . . . . 1.1200000000000001 110.697 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.9 8.89 18.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 1.24 112.426 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.99 120.07 11.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.863 -1.148 . . . . 1.3100000000000001 109.435 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -10.86 56.03 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.204 1.002 . . . . 1.3500000000000001 110.458 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -82.13 -53.2 6.28 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.656 0.741 . . . . 2.1600000000000001 109.857 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.01 -27.38 69.37 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.364 1.078 . . . . 1.24 110.17 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' CD ' ' NH2' ' A' ' 47' ' ' ARG . 87.3 tt0 -67.24 -48.4 67.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.626 -0.671 . . . . 1.28 110.397 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.17 -31.04 72.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 1.79 110.312 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.23 -57.25 4.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 1.29 109.836 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -48.6 -45.1 14.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.352 -0.939 . . . . 1.1399999999999999 110.614 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.64 -42.69 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 1.3200000000000001 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.72 82.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.052 . . . . 1.3700000000000001 110.922 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.73 -39.89 91.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.04 -1.037 . . . . 1.3999999999999999 110.608 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.96 -43.45 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 1.23 110.558 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -85.34 -28.76 25.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.048 . . . . 2.5099999999999998 112.271 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 43.1 t0 -88.66 -33.11 17.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.004 . . . . 1.5900000000000001 111.497 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -113.76 11.31 18.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 2.3799999999999999 110.191 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 44.55 48.84 8.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 118.902 -1.119 . . . . 1.6200000000000001 110.854 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.3 mtt -99.48 157.45 16.43 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.478 0.656 . . . . 1.8899999999999999 110.142 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.6 p -73.31 170.57 14.76 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.584 0.707 . . . . 1.27 109.775 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.83 75.12 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.215 -0.928 . . . . 1.1599999999999999 110.004 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 -42.09 64.62 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.959 0.885 . . . . 2.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.17 35.18 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.476 0.655 . . . . 1.25 110.682 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.11 -0.994 . . . . 1.1299999999999999 110.394 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 1.0800000000000001 110.805 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.54 -38.23 90.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.968 -1.082 . . . . 2.02 110.86 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -56.59 -55.45 33.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.064 -1.022 . . . . 1.26 111.525 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.42 -47.2 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.723 -0.791 . . . . 1.1799999999999999 109.972 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.15 -22.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.522 -0.736 . . . . 1.1899999999999999 110.882 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.15 -41.57 90.23 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.25 -0.906 . . . . 2.2000000000000002 110.174 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -25.43 34.21 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.654 -1.26 . . . . 0.85999999999999999 112.95 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -68.26 -31.23 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.449 -1.618 . . . . 2.0 110.311 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -50.54 9.78 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.411 0.624 . . . . 1.3200000000000001 110.548 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -33.88 75.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.389 -0.819 . . . . 2.1400000000000001 110.125 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.26 96.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.083 -1.011 . . . . 1.3799999999999999 110.424 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.28 -23.25 66.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.932 -1.105 . . . . 1.3500000000000001 110.418 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -72.38 -19.43 61.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.904 0.859 . . . . 1.95 110.911 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.32 -12.99 59.93 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.227 1.013 . . . . 1.71 110.539 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.7 mt -85.35 142.05 29.59 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.75 -0.833 . . . . 1.71 108.75 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.51 47.54 1.02 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 2.8300000000000001 111.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -120.37 143.25 48.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.308 -0.87 . . . . 1.5800000000000001 109.319 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.21 -32.0 73.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 2.7999999999999998 110.676 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.74 -54.44 6.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 1.27 110.304 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.84 -36.73 79.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 1.5800000000000001 110.179 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -65.37 -56.59 11.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 2.9199999999999999 109.64 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.3 -19.45 34.76 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.498 -1.281 . . . . 2.2000000000000002 110.401 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.28 -26.09 61.85 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 123.375 1.56 . . . . 2.5299999999999998 108.549 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.77 81.16 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.448 -1.251 . . . . 1.45 109.141 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.89 76.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.451 0.643 . . . . 1.5 110.183 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -68.05 -28.79 67.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 1.3500000000000001 111.215 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.88 -39.62 52.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.725 -0.79 . . . . 1.23 109.692 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -58.81 -37.36 76.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.976 -1.09 . . . . 3.73 109.361 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -62.48 -32.65 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.78 -0.646 . . . . 1.3200000000000001 110.333 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.44 -43.13 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 1.2 110.524 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -38.44 68.9 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.772 -1.204 . . . . 0.48999999999999999 110.153 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -57.19 -43.48 82.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.505 -0.997 . . . . 3.1099999999999999 109.69 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 140' ' ' ASN . 39.9 mtt-85 -63.68 -52.53 60.23 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.481 -0.888 . . . . 2.9500000000000002 109.642 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -50.67 -40.0 52.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 120.121 -0.632 . . . . 1.73 110.124 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.9 mt -60.95 -43.08 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 1.22 110.306 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -66.29 -25.66 66.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.165 -0.959 . . . . 2.7799999999999998 111.558 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' ARG . 13.5 m120 -81.36 -32.54 32.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 2.0299999999999998 110.86 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.91 -38.27 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.519 -0.872 . . . . 1.2 109.597 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.3 mt -89.24 -9.46 50.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.347 1.07 . . . . 1.28 111.055 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.62 26.12 70.52 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.389 -1.386 . . . . 0.68999999999999995 112.668 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.89 146.22 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.846 -0.798 . . . . 1.3100000000000001 108.846 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.88 146.65 54.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.387 -0.821 . . . . 2.8799999999999999 109.934 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.09 138.94 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.111 -1.07 . . . . 1.3600000000000001 108.111 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.1 mp -79.15 125.79 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.169 -0.957 . . . . 1.9299999999999999 108.975 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -95.91 94.19 7.47 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.711 -1.218 . . . . 1.54 107.711 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.03 -21.44 56.84 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.075 0.94 . . . . 1.3400000000000001 110.42 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.0 t -80.47 8.35 7.88 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.096 -1.003 . . . . 1.98 111.491 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.76 25.15 11.18 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.481 0.658 . . . . 1.3799999999999999 111.392 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 22.7 mt -73.61 157.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.393 -0.817 . . . . 1.3999999999999999 109.471 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -131.72 -23.12 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 2.7400000000000002 111.269 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.97 133.04 54.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.545 -0.909 . . . . 1.4099999999999999 108.545 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.71 116.68 7.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 1.3 109.127 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.35 176.94 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.551 -0.718 . . . . 1.28 109.096 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 mt -88.02 145.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.595 -0.691 . . . . 1.1499999999999999 109.213 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 32.4 tp -98.17 123.81 42.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.244 -0.91 . . . . 1.2 108.863 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -123.87 129.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.247 -1.019 . . . . 1.1599999999999999 108.247 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.25 150.74 16.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 1.2 108.998 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.75 -31.82 70.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.782 -1.199 . . . . 1.3200000000000001 109.561 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.17 151.18 1.01 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.85 -0.796 . . . . 2.3399999999999999 108.85 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.64 139.43 53.02 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.308 -0.997 . . . . 1.26 108.308 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.8 p -91.25 149.69 40.2 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 1.3600000000000001 109.016 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.419 ' O ' ' OG1' ' A' ' 168' ' ' THR . 81.4 Cg_exo -37.48 -53.04 1.46 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 122.087 1.858 . . . . 0.63 112.92 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 m -50.93 -58.24 6.53 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.4 -0.92 . . . . 1.0700000000000001 110.917 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.5 -39.81 67.92 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.494 -0.882 . . . . 1.25 110.261 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.533 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 61.1 p -70.71 -31.77 68.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.419 -0.801 . . . . 1.1799999999999999 110.058 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.92 67.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.498 -0.751 . . . . 1.1399999999999999 111.009 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -103.18 -4.73 24.01 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.048 0.928 . . . . 1.71 112.566 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.05 151.94 17.61 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.014 -0.674 . . . . 1.22 109.434 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.7 114.96 27.06 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.408 1.099 . . . . 2.5499999999999998 108.544 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.0 mt -78.69 -11.06 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 1.96 110.891 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.03 -20.29 25.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.185 -0.947 . . . . 2.46 111.594 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -105.07 -12.47 16.13 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.659 1.219 . . . . 2.4199999999999999 111.251 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.79 127.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.533 -0.914 . . . . 1.1599999999999999 108.533 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.84 -7.34 49.66 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.643 1.211 . . . . 1.95 111.525 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.59 171.54 38.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.41999999999999998 109.68 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.1 m-85 -127.44 133.9 49.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.003 -1.11 . . . . 0.52000000000000002 108.003 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 63.2 mt -137.99 104.19 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 107.307 -1.368 . . . . 1.1599999999999999 107.307 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -126.6 173.79 9.18 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.915 -1.116 . . . . 1.22 110.414 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 205' ' ' THR . 7.2 m-20 -101.54 55.51 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.246 -0.65 . . . . 2.2400000000000002 109.246 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.9 154.37 18.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.345 -0.847 . . . . 1.6499999999999999 109.883 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -50.46 -46.41 45.55 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.505 -1.331 . . . . 2.1000000000000001 110.111 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.52 -29.28 11.71 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 121.632 -0.922 . . . . 1.8400000000000001 111.955 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -59.14 -72.46 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.362 -1.335 . . . . 5.7800000000000002 109.962 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 72.4 p -104.57 42.29 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 3.2400000000000002 109.455 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.402 ' OG ' ' OG1' ' A' ' 190' ' ' THR . 10.8 t -85.2 124.44 31.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 2.1099999999999999 108.788 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.533 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 77.6 t60 -57.2 -40.41 77.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.313 -0.867 . . . . 1.0600000000000001 109.752 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.402 ' OG1' ' OG ' ' A' ' 188' ' ' SER . 40.1 p -54.51 -51.83 63.89 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.234 -0.986 . . . . 2.0899999999999999 110.574 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.3 t -48.57 -43.17 35.49 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.592 -0.843 . . . . 1.8799999999999999 110.79 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.2 mt -62.12 -28.7 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.342 -0.943 . . . . 2.0099999999999998 110.594 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.1 mtp -69.85 -44.22 70.32 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.684 1.23 . . . . 1.27 109.361 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.17 -40.91 87.09 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.156 -0.929 . . . . 1.1799999999999999 111.18 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -65.89 -45.52 81.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.212 . . . . 3.5800000000000001 110.742 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.8 m -69.13 -36.73 77.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 1.1399999999999999 110.047 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 199' ' ' LEU . 7.9 mt -93.56 -7.11 45.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.782 1.277 . . . . 1.28 111.676 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.4 mt-10 52.41 6.52 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.601 0.963 . . . . 1.49 113.601 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 197' ' ' LEU . 71.0 mt -66.79 147.84 98.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 1.28 108.976 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.64 140.3 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.873 1.715 . . . . 0.69999999999999996 110.348 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.108 -1.437 . . . . 1.1899999999999999 109.813 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.0 mt -151.54 153.7 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.001 -1.111 . . . . 1.25 108.001 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.5 m -136.49 -31.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 1.29 112.201 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.96 44.84 2.65 Favored Glycine 0 N--CA 1.48 1.59 0 C-N-CA 119.704 -1.236 . . . . 0.92000000000000004 110.823 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 63.6 p -69.46 -12.18 61.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 122.475 1.131 . . . . 1.3100000000000001 110.985 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.36 -94.53 0.48 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -129.86 37.82 3.89 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.549 -0.971 . . . . 1.9199999999999999 112.114 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.89 -30.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.9 -1.125 . . . . 1.27 109.663 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 27.3 p -63.86 -15.58 59.29 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.694 0.759 . . . . 1.3400000000000001 111.343 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 10.23 38.42 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.027 0.917 . . . . 2.0699999999999998 111.191 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -137.81 4.38 2.55 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.813 0.816 . . . . 2.8599999999999999 111.938 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.01 153.09 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.715 0.769 . . . . 1.3 109.975 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.71 168.09 11.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.136 -1.061 . . . . 2.48 108.136 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 45.5 p-10 -70.56 150.89 45.63 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.583 -1.247 . . . . 2.6200000000000001 108.85 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 36.2 m-20 77.86 -5.46 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.372 0.878 . . . . 2.3999999999999999 113.372 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.43 142.72 47.71 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.101 -1.039 . . . . 1.99 108.805 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -88.45 114.26 24.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.996 -1.065 . . . . 1.54 108.465 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 38.8 mt -124.65 147.99 48.21 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.594 0.711 . . . . 1.25 109.615 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.77 124.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 107.096 -1.446 . . . . 1.26 107.096 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -94.42 119.56 33.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.577 -1.268 . . . . 1.1799999999999999 107.577 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 223' ' ' VAL . 22.2 t0 -91.62 -36.04 13.88 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.671 1.224 . . . . 2.2200000000000002 111.54 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 41.8 17.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.872 0.844 . . . . 1.2 113.263 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.4 t -111.71 -62.59 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.998 -1.112 . . . . 1.48 107.998 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -93.58 16.76 12.98 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 123.403 1.573 . . . . 2.8199999999999998 108.879 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 53.53 62.0 2.85 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 118.74 -1.184 . . . . 2.1099999999999999 109.415 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -154.58 144.16 21.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.314 -0.954 . . . . 2.6499999999999999 109.855 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.92 139.76 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.551 -0.907 . . . . 1.29 108.551 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -102.91 131.22 49.99 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.657 -0.868 . . . . 1.4199999999999999 108.657 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.2 124.98 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.192 0.996 . . . . 1.26 109.135 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.7 t30 53.87 54.93 12.29 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 2.1499999999999999 112.74 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.21 148.62 50.16 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.814 2.342 . . . . 0.81999999999999995 111.184 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.4 p -74.86 150.66 39.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 2.1099999999999999 109.557 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -51.07 -40.75 59.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.297 -0.877 . . . . 3.1699999999999999 110.369 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -54.87 -36.63 65.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.368 -0.832 . . . . 3.0600000000000001 110.37 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.56 -42.07 48.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 122.102 0.953 . . . . 1.6499999999999999 108.886 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.98 -61.55 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 118.911 -1.116 . . . . 1.47 109.479 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -35.7 13.31 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.361 -0.936 . . . . 2.54 110.917 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -68.03 -36.92 80.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.061 -1.025 . . . . 3.0 110.187 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.5 mtp -79.9 -37.01 35.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 1.6299999999999999 110.896 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -58.26 -32.62 68.55 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.283 -0.967 . . . . 3.1600000000000001 110.202 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.9 -66.01 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 2.0899999999999999 109.414 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.49 -56.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.981 -1.088 . . . . 2.5699999999999998 110.845 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -45.22 -61.38 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.369 -0.932 . . . . 3.5899999999999999 110.923 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.0 -24.4 67.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.144 0.973 . . . . 1.76 110.033 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -66.79 -20.7 66.0 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.453 1.121 . . . . 3.21 109.499 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.4 -47.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.336 1.065 . . . . 2.3500000000000001 108.55 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.19 75.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.335 1.064 . . . . 2.3999999999999999 108.608 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 t -74.44 -33.64 62.98 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.02 0.914 . . . . 3.0299999999999998 109.261 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -68.92 -26.31 65.02 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.637 1.208 . . . . 3.4100000000000001 109.301 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -74.16 -44.01 55.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.467 1.127 . . . . 4.1799999999999997 108.375 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.3 -17.71 64.34 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 123.605 1.669 . . . . 4.4299999999999997 108.993 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -73.89 -19.86 60.58 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 123.337 1.541 . . . . 5.4199999999999999 108.616 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.79 -28.45 64.66 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.793 1.759 . . . . 6.1100000000000003 107.59 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.77 -11.08 60.64 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 113.595 -1.639 . . . . 7.3700000000000001 109.255 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 257' ' ' LYS . 16.1 mttp -93.94 -6.15 46.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.281 -1.327 . . . . 8.3000000000000007 110.994 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 mt -75.01 5.01 5.67 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 123.966 1.841 . . . . 9.0500000000000007 110.085 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 255' ' ' LYS . 10.2 mtpt -95.34 -23.43 17.19 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.7 -2.046 . . . . 10.56 109.795 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 258' ' ' ASP . 0.4 OUTLIER -90.76 1.56 56.78 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-O 124.105 1.907 . . . . 11.32 109.58 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.542 ' HG2' HH11 ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 113.311 -1.768 . . . . 12.74 108.334 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.601 . . . . 3.66 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mt -73.98 100.98 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.297 -1.001 . . . . 1.12 108.297 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.0 m -95.22 120.01 34.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.112 -0.992 . . . . 1.45 108.713 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.91 -152.9 24.13 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.11 -1.996 . . . . 0.92 108.11 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 5' ' ' ILE . 31.4 mt -102.06 -2.09 9.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.973 1.368 . . . . 1.05 111.719 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tp 55.12 101.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.178 -1.009 . . . . 0.88 110.856 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.95 -37.87 14.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.639 -0.824 . . . . 0.78 111.704 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -148.91 142.44 16.11 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.68 141.09 15.22 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.588 2.192 . . . . 0.86 112.695 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.916 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.63 170.93 23.01 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.189 -1.564 . . . . 0.78 109.189 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.3 135.55 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.74 108.288 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.32 148.87 38.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.45 109.249 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.6 m-85 -116.48 136.61 52.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.027 -1.101 . . . . 0.64 108.027 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.53 161.93 30.27 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 118.834 -1.651 . . . . 0.45 109.603 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -75.45 158.05 33.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.721 -0.87 . . . . 1.88 109.288 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.56 123.82 29.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.234 -0.916 . . . . 0.59 109.463 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.18 95.19 5.8 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 106.269 -1.752 . . . . 0.64 106.269 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.62 137.92 34.36 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.182 -1.044 . . . . 0.74 108.182 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 158' ' ' LEU . 36.3 mt -103.2 106.92 17.55 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 107.869 -1.16 . . . . 0.74 107.869 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -100.45 137.95 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.12 -1.067 . . . . 1.87 108.12 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -129.32 144.92 51.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 2.58 109.371 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.38 132.81 35.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.278 -1.008 . . . . 2.14 108.278 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.44 146.06 54.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 1.93 109.18 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.92 130.83 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.364 -0.835 . . . . 0.68 108.871 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.26 124.0 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.315 -0.994 . . . . 0.84 108.315 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.5 mt -91.37 135.95 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.305 -0.872 . . . . 0.79 108.859 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -90.98 123.54 34.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 1.37 108.639 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -99.09 25.45 6.75 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.025 0.917 . . . . 2.62 111.345 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -77.55 140.97 39.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 2.35 109.509 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -84.94 128.5 34.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 2.35 108.007 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.29 171.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.78 109.813 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -100.86 166.46 10.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 1.04 109.254 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.58 -5.01 0.74 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.073 -1.017 . . . . 1.05 111.808 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.9 -36.95 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.733 -0.604 . . . . 2.47 110.61 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.6 -8.15 35.75 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.326 1.06 . . . . 1.46 111.634 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.62 -51.58 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 119.161 -1.016 . . . . 0.77 110.455 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -52.57 -35.48 53.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.428 -0.795 . . . . 1.46 110.873 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.58 -40.02 84.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.106 -0.996 . . . . 2.29 110.981 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.93 -38.49 86.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.68 -1.263 . . . . 1.3 110.389 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.99 -40.05 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.385 -0.822 . . . . 0.76 110.315 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -65.13 -42.37 93.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 1.5 110.252 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -66.65 -32.1 73.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 2.66 110.425 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -83.48 -48.46 10.27 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.289 -0.882 . . . . 0.75 110.682 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.79 -50.04 68.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.255 -0.978 . . . . 0.83 109.123 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.06 -31.81 69.6 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 122.241 1.02 . . . . 0.78 109.023 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.49 -49.79 74.69 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.416 -1.474 . . . . 0.57 109.416 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.9 ttp180 -58.96 -27.03 64.96 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.187 -1.184 . . . . 2.83 110.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -37.9 78.17 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.992 0.901 . . . . 0.65 110.107 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -83.43 -49.67 9.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.634 -0.666 . . . . 2.57 110.753 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.32 73.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.427 -0.909 . . . . 0.51 109.848 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -62.12 -40.13 94.87 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.326 1.06 . . . . 1.36 109.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.56 -39.16 74.12 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.636 -0.711 . . . . 0.6 109.832 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.87 -61.72 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.943 . . . . 1.36 110.393 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.47 -38.07 63.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 1.38 110.243 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -58.18 -39.44 78.9 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 1.27 110.62 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.0 m -67.77 -47.77 68.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.6 110.436 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.6 -39.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.53 110.438 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -45.61 -47.96 14.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.99 111.341 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -70.15 -28.69 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.297 -0.877 . . . . 0.59 110.407 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -69.13 -27.46 65.59 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.463 1.125 . . . . 1.81 110.178 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.56 52.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.604 0.716 . . . . 0.48 109.68 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.47 -30.42 24.66 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.977 -1.106 . . . . 0.58 110.557 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.28 -19.3 31.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.06 -1.259 . . . . 1.39 111.209 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -93.62 -46.79 7.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.914 -0.584 . . . . 0.82 111.03 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.04 -24.98 11.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.329 -0.857 . . . . 0.99 112.724 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.47 165.05 12.68 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.25 -0.906 . . . . 0.55 112.06 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -54.72 -11.2 0.55 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.762 -0.846 . . . . 2.59 112.734 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.68 -37.04 85.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 2.2 111.335 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -89.97 -17.62 27.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.822 -1.174 . . . . 1.79 112.434 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.13 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 1.54 110.452 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.69 78.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.64 110.814 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.81 -41.87 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.374 -0.93 . . . . 0.58 110.078 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -75.13 -25.8 58.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.309 1.052 . . . . 0.62 109.957 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -67.16 -35.03 78.81 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.726 0.774 . . . . 1.23 109.95 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.82 -37.48 66.01 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.259 -1.136 . . . . 0.52 110.259 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -58.82 -49.57 77.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -1.097 . . . . 1.29 110.547 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.3 mt -58.41 -36.41 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.55 110.13 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 ttt -58.87 -41.66 87.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 1.89 109.954 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.23 -53.39 58.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.53 110.555 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.6 tp -56.36 -39.73 73.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.725 -0.61 . . . . 0.43 110.697 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.9 8.89 18.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 1.24 112.426 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.99 120.07 11.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.863 -1.148 . . . . 1.31 109.435 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -10.86 56.03 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.204 1.002 . . . . 1.35 110.458 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -82.13 -53.2 6.28 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.656 0.741 . . . . 2.16 109.857 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.01 -27.38 69.37 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.364 1.078 . . . . 0.6 110.17 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' CD ' HH22 ' A' ' 47' ' ' ARG . 87.3 tt0 -67.24 -48.4 67.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.626 -0.671 . . . . 1.28 110.397 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.17 -31.04 72.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 1.28 110.312 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.23 -57.25 4.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 1.29 109.836 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -48.6 -45.1 14.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.352 -0.939 . . . . 0.58 110.614 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.64 -42.69 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 0.78 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.72 82.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.052 . . . . 0.86 110.922 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.73 -39.89 91.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.04 -1.037 . . . . 0.79 110.608 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.96 -43.45 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.71 110.558 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -85.34 -28.76 25.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.048 . . . . 2.05 112.271 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 95' ' ' ASP . 43.1 t0 -88.66 -33.11 17.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.004 . . . . 1.59 111.497 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -113.76 11.31 18.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 1.89 110.191 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 44.55 48.84 8.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 118.902 -1.119 . . . . 1.31 110.854 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.3 mtt -99.48 157.45 16.43 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.478 0.656 . . . . 1.28 110.142 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.6 p -73.31 170.57 14.76 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.584 0.707 . . . . 0.62 109.775 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.83 75.12 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.215 -0.928 . . . . 0.47 110.004 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 -42.09 64.62 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.959 0.885 . . . . 2.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.17 35.18 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.476 0.655 . . . . 0.56 110.682 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.11 -0.994 . . . . 0.48 110.394 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.44 110.805 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.54 -38.23 90.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.968 -1.082 . . . . 1.42 110.86 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -56.59 -55.45 33.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.064 -1.022 . . . . 1.26 111.525 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.42 -47.2 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.723 -0.791 . . . . 0.61 109.972 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.15 -22.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.522 -0.736 . . . . 0.64 110.882 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.15 -41.57 90.23 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.25 -0.906 . . . . 2.2 110.174 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -25.43 34.21 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.654 -1.26 . . . . 0.82 112.95 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -68.26 -31.23 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.449 -1.618 . . . . 1.27 110.311 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -50.54 9.78 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.411 0.624 . . . . 0.91 110.548 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -33.88 75.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.389 -0.819 . . . . 1.73 110.125 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.26 96.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.083 -1.011 . . . . 1.04 110.424 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.28 -23.25 66.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.932 -1.105 . . . . 1.03 110.418 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -72.38 -19.43 61.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.904 0.859 . . . . 1.95 110.911 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.32 -12.99 59.93 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.227 1.013 . . . . 1.71 110.539 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 123' ' ' LEU . 7.7 mt -85.35 142.05 29.59 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.75 -0.833 . . . . 1.26 108.75 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.51 47.54 1.02 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 2.83 111.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -120.37 143.25 48.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.308 -0.87 . . . . 1.58 109.319 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.21 -32.0 73.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 2.8 110.676 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.74 -54.44 6.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 1.02 110.304 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 118' ' ' LEU . 18.6 mt -60.84 -36.73 79.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 1.06 110.179 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -65.37 -56.59 11.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 2.39 109.64 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.3 -19.45 34.76 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.498 -1.281 . . . . 2.2 110.401 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.28 -26.09 61.85 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 123.375 1.56 . . . . 2.09 108.549 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.77 81.16 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.448 -1.251 . . . . 0.86 109.141 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.89 76.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.451 0.643 . . . . 0.9 110.183 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -68.05 -28.79 67.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 1.35 111.215 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.88 -39.62 52.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.725 -0.79 . . . . 0.58 109.692 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -58.81 -37.36 76.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.976 -1.09 . . . . 3.22 109.361 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -62.48 -32.65 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.78 -0.646 . . . . 1.32 110.333 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.44 -43.13 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.5 110.524 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -38.44 68.9 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.772 -1.204 . . . . 0.44 110.153 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -57.19 -43.48 82.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.505 -0.997 . . . . 2.71 109.69 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 140' ' ' ASN . 39.9 mtt-85 -63.68 -52.53 60.23 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.481 -0.888 . . . . 2.2 109.642 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -50.67 -40.0 52.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 120.121 -0.632 . . . . 1.13 110.124 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.9 mt -60.95 -43.08 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.54 110.306 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -66.29 -25.66 66.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.165 -0.959 . . . . 2.32 111.558 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' ARG . 13.5 m120 -81.36 -32.54 32.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 1.26 110.86 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.91 -38.27 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.519 -0.872 . . . . 0.62 109.597 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.3 mt -89.24 -9.46 50.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.347 1.07 . . . . 0.67 111.055 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.62 26.12 70.52 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.389 -1.386 . . . . 0.68 112.668 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.89 146.22 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.846 -0.798 . . . . 0.77 108.846 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.88 146.65 54.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.387 -0.821 . . . . 2.4 109.934 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.09 138.94 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.111 -1.07 . . . . 0.87 108.111 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.744 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.1 mp -79.15 125.79 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.169 -0.957 . . . . 1.32 108.975 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -95.91 94.19 7.47 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.711 -1.218 . . . . 1.54 107.711 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.03 -21.44 56.84 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.075 0.94 . . . . 0.77 110.42 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.0 t -80.47 8.35 7.88 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.096 -1.003 . . . . 1.57 111.491 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.76 25.15 11.18 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.481 0.658 . . . . 0.82 111.392 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 153' ' ' GLN . 22.7 mt -73.61 157.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.393 -0.817 . . . . 0.82 109.471 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.431 ' N ' HG22 ' A' ' 152' ' ' ILE . 70.2 mt-30 -131.72 -23.12 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 2.11 111.269 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.97 133.04 54.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.545 -0.909 . . . . 1.41 108.545 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.71 116.68 7.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 1.3 109.127 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.35 176.94 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.551 -0.718 . . . . 0.57 109.096 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 mt -88.02 145.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.595 -0.691 . . . . 0.43 109.213 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 19' ' ' LEU . 32.4 tp -98.17 123.81 42.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.244 -0.91 . . . . 0.56 108.863 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -123.87 129.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.247 -1.019 . . . . 0.54 108.247 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.25 150.74 16.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.62 108.998 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.75 -31.82 70.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.782 -1.199 . . . . 0.8 109.561 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.17 151.18 1.01 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.85 -0.796 . . . . 2.34 108.85 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.64 139.43 53.02 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.308 -0.997 . . . . 0.65 108.308 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.8 p -91.25 149.69 40.2 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.74 109.016 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.48 -53.04 1.46 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 122.087 1.858 . . . . 0.6 112.92 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 m -50.93 -58.24 6.53 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.4 -0.92 . . . . 0.63 110.917 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.5 -39.81 67.92 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.494 -0.882 . . . . 1.25 110.261 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.1 p -70.71 -31.77 68.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.419 -0.801 . . . . 0.5 110.058 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.92 67.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.498 -0.751 . . . . 0.51 111.009 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -103.18 -4.73 24.01 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.048 0.928 . . . . 1.17 112.566 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.05 151.94 17.61 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.014 -0.674 . . . . 0.61 109.434 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 176' ' ' VAL . 1.4 m-20 -97.7 114.96 27.06 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.408 1.099 . . . . 2.12 108.544 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.0 mt -78.69 -11.06 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 1.34 110.891 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.03 -20.29 25.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.185 -0.947 . . . . 1.97 111.594 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -105.07 -12.47 16.13 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.659 1.219 . . . . 1.9 111.251 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.9 t -98.79 127.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.533 -0.914 . . . . 0.48 108.533 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.84 -7.34 49.66 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.643 1.211 . . . . 1.39 111.525 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.59 171.54 38.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.38 109.68 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.1 m-85 -127.44 133.9 49.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.003 -1.11 . . . . 0.46 108.003 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.569 HG22 HG21 ' A' ' 205' ' ' THR . 63.2 mt -137.99 104.19 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 107.307 -1.368 . . . . 0.59 107.307 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -126.6 173.79 9.18 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.915 -1.116 . . . . 0.67 110.414 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -101.54 55.51 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.246 -0.65 . . . . 2.24 109.246 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.9 154.37 18.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.345 -0.847 . . . . 1.11 109.883 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -50.46 -46.41 45.55 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.505 -1.331 . . . . 1.63 110.111 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.52 -29.28 11.71 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 121.632 -0.922 . . . . 1.47 111.955 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -59.14 -72.46 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.362 -1.335 . . . . 5.24 109.962 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 72.4 p -104.57 42.29 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 2.92 109.455 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.8 t -85.2 124.44 31.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 1.6 108.788 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -57.2 -40.41 77.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.313 -0.867 . . . . 0.92 109.752 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.1 p -54.51 -51.83 63.89 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.234 -0.986 . . . . 1.59 110.574 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.3 t -48.57 -43.17 35.49 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.592 -0.843 . . . . 1.42 110.79 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.2 mt -62.12 -28.7 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.342 -0.943 . . . . 1.41 110.594 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.1 mtp -69.85 -44.22 70.32 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.684 1.23 . . . . 0.86 109.361 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.17 -40.91 87.09 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.156 -0.929 . . . . 0.59 111.18 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -65.89 -45.52 81.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.212 . . . . 3.06 110.742 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.8 m -69.13 -36.73 77.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 0.73 110.047 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.56 -7.11 45.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.782 1.277 . . . . 0.67 111.676 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.4 mt-10 52.41 6.52 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.601 0.963 . . . . 1.49 113.601 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.79 147.84 98.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 0.64 108.976 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.64 140.3 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.873 1.715 . . . . 0.59 110.348 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.108 -1.437 . . . . 0.55 109.813 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.0 mt -151.54 153.7 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.001 -1.111 . . . . 0.63 108.001 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.5 m -136.49 -31.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.77 112.201 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.96 44.84 2.65 Favored Glycine 0 N--CA 1.48 1.59 0 C-N-CA 119.704 -1.236 . . . . 0.87 110.823 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 180' ' ' ILE . 63.6 p -69.46 -12.18 61.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 122.475 1.131 . . . . 0.89 110.985 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.36 -94.53 0.48 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.829 -0.908 . . . . 0.93 110.829 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -129.86 37.82 3.89 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.549 -0.971 . . . . 1.6 112.114 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.89 -30.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.9 -1.125 . . . . 0.75 109.663 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.476 HG23 ' OD1' ' A' ' 182' ' ' ASP . 27.3 p -63.86 -15.58 59.29 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.694 0.759 . . . . 0.84 111.343 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 10.23 38.42 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.027 0.917 . . . . 1.61 111.191 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -137.81 4.38 2.55 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.813 0.816 . . . . 2.3 111.938 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.01 153.09 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.715 0.769 . . . . 0.76 109.975 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.71 168.09 11.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.136 -1.061 . . . . 2.01 108.136 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 45.5 p-10 -70.56 150.89 45.63 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.583 -1.247 . . . . 2.19 108.85 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 36.2 m-20 77.86 -5.46 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.372 0.878 . . . . 2.4 113.372 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.43 142.72 47.71 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.101 -1.039 . . . . 1.99 108.805 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -88.45 114.26 24.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.996 -1.065 . . . . 1.3 108.465 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 38.8 mt -124.65 147.99 48.21 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.594 0.711 . . . . 0.53 109.615 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.77 124.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 107.096 -1.446 . . . . 0.6 107.096 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -94.42 119.56 33.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.577 -1.268 . . . . 0.57 107.577 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 223' ' ' VAL . 22.2 t0 -91.62 -36.04 13.88 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.671 1.224 . . . . 2.22 111.54 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.8 17.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.872 0.844 . . . . 0.75 113.263 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.4 t -111.71 -62.59 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.998 -1.112 . . . . 0.92 107.998 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -93.58 16.76 12.98 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 123.403 1.573 . . . . 2.36 108.879 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 53.53 62.0 2.85 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 118.74 -1.184 . . . . 1.42 109.415 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -154.58 144.16 21.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.314 -0.954 . . . . 1.97 109.855 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.92 139.76 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.551 -0.907 . . . . 0.65 108.551 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -102.91 131.22 49.99 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.657 -0.868 . . . . 0.97 108.657 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.2 124.98 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.192 0.996 . . . . 0.67 109.135 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.7 t30 53.87 54.93 12.29 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 1.45 112.74 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.21 148.62 50.16 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.814 2.342 . . . . 0.82 111.184 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.4 p -74.86 150.66 39.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 1.62 109.557 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -51.07 -40.75 59.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.297 -0.877 . . . . 2.6 110.369 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -54.87 -36.63 65.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.368 -0.832 . . . . 3.06 110.37 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.56 -42.07 48.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 122.102 0.953 . . . . 1.14 108.886 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.98 -61.55 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 118.911 -1.116 . . . . 1.04 109.479 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -35.7 13.31 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.361 -0.936 . . . . 2.54 110.917 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -68.03 -36.92 80.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.061 -1.025 . . . . 2.6 110.187 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.5 mtp -79.9 -37.01 35.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 1.23 110.896 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -58.26 -32.62 68.55 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.283 -0.967 . . . . 2.67 110.202 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.9 -66.01 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 1.66 109.414 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.49 -56.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.981 -1.088 . . . . 2.2 110.845 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -45.22 -61.38 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.369 -0.932 . . . . 3.0 110.923 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.0 -24.4 67.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.144 0.973 . . . . 1.76 110.033 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -66.79 -20.7 66.0 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.453 1.121 . . . . 2.78 109.499 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.4 -47.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.336 1.065 . . . . 2.06 108.55 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.19 75.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.335 1.064 . . . . 2.4 108.608 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 t -74.44 -33.64 62.98 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.02 0.914 . . . . 2.87 109.261 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -68.92 -26.31 65.02 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.637 1.208 . . . . 3.41 109.301 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -74.16 -44.01 55.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.467 1.127 . . . . 3.88 108.375 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.3 -17.71 64.34 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 123.605 1.669 . . . . 4.43 108.993 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -73.89 -19.86 60.58 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 123.337 1.541 . . . . 5.42 108.616 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.415 HD12 HD12 ' A' ' 256' ' ' LEU . 5.5 tp -70.79 -28.45 64.66 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.793 1.759 . . . . 6.1 107.59 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.77 -11.08 60.64 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 113.595 -1.639 . . . . 7.37 109.255 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 257' ' ' LYS . 16.1 mttp -93.94 -6.15 46.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.281 -1.327 . . . . 8.01 110.994 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.415 HD12 HD12 ' A' ' 253' ' ' LEU . 3.1 mt -75.01 5.01 5.67 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 123.966 1.841 . . . . 9.05 110.085 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 255' ' ' LYS . 10.2 mtpt -95.34 -23.43 17.19 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.7 -2.046 . . . . 10.56 109.795 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 258' ' ' ASP . 0.4 OUTLIER -90.76 1.56 56.78 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-O 124.105 1.907 . . . . 11.32 109.58 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.568 HH11 ' HG2' ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 113.311 -1.768 . . . . 12.42 108.334 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.601 . . . . 3.6600000000000001 109.379 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mt -73.98 100.98 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.297 -1.001 . . . . 1.1200000000000001 108.297 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.0 m -95.22 120.01 34.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.112 -0.992 . . . . 1.45 108.713 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.91 -152.9 24.13 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 108.11 -1.996 . . . . 0.92000000000000004 108.11 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 5' ' ' ILE . 31.4 mt -102.06 -2.09 9.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 122.973 1.368 . . . . 1.05 111.719 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tp 55.12 101.17 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 119.178 -1.009 . . . . 0.88 110.856 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 201' ' ' ALA . . . -89.95 -37.87 14.06 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.639 -0.824 . . . . 0.78000000000000003 111.704 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -148.91 142.44 16.11 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 107.701 -1.222 . . . . 1.5 107.701 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.68 141.09 15.22 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.588 2.192 . . . . 0.85999999999999999 112.695 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.916 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.63 170.93 23.01 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 109.189 -1.564 . . . . 0.78000000000000003 109.189 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.5 mt -129.3 135.55 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.481 -1.011 . . . . 0.73999999999999999 108.288 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.32 148.87 38.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.219 -0.926 . . . . 0.45000000000000001 109.249 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.6 m-85 -116.48 136.61 52.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.027 -1.101 . . . . 0.64000000000000001 108.027 178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.53 161.93 30.27 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 118.834 -1.651 . . . . 0.45000000000000001 109.603 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -75.45 158.05 33.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.721 -0.87 . . . . 1.8799999999999999 109.288 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -82.56 123.82 29.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.234 -0.916 . . . . 0.58999999999999997 109.463 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.18 95.19 5.8 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 106.269 -1.752 . . . . 0.64000000000000001 106.269 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.62 137.92 34.36 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.182 -1.044 . . . . 0.73999999999999999 108.182 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 158' ' ' LEU . 36.3 mt -103.2 106.92 17.55 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 107.869 -1.16 . . . . 0.73999999999999999 107.869 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -100.45 137.95 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.12 -1.067 . . . . 1.8700000000000001 108.12 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -129.32 144.92 51.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.248 -0.907 . . . . 2.5800000000000001 109.371 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.38 132.81 35.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.278 -1.008 . . . . 2.1400000000000001 108.278 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.44 146.06 54.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 109.18 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.92 130.83 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.364 -0.835 . . . . 0.68000000000000005 108.871 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.26 124.0 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.315 -0.994 . . . . 0.83999999999999997 108.315 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.5 mt -91.37 135.95 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.305 -0.872 . . . . 0.79000000000000004 108.859 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -90.98 123.54 34.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 1.3700000000000001 108.639 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -99.09 25.45 6.75 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.025 0.917 . . . . 2.6200000000000001 111.345 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -77.55 140.97 39.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 2.3500000000000001 109.509 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -84.94 128.5 34.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.007 -1.108 . . . . 2.3500000000000001 108.007 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.2 pt -92.29 171.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.78000000000000003 109.813 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.2 p -100.86 166.46 10.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.558 -0.714 . . . . 1.04 109.254 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.58 -5.01 0.74 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.073 -1.017 . . . . 1.05 111.808 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.9 -36.95 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.733 -0.604 . . . . 2.4700000000000002 110.61 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -95.6 -8.15 35.75 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 122.326 1.06 . . . . 1.46 111.634 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.62 -51.58 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 119.161 -1.016 . . . . 0.77000000000000002 110.455 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -52.57 -35.48 53.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.428 -0.795 . . . . 1.46 110.873 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -67.58 -40.02 84.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.106 -0.996 . . . . 2.29 110.981 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -60.93 -38.49 86.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.68 -1.263 . . . . 1.3 110.389 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.99 -40.05 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.385 -0.822 . . . . 0.76000000000000001 110.315 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -65.13 -42.37 93.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.369 -0.832 . . . . 1.5 110.252 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -66.65 -32.1 73.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 2.6600000000000001 110.425 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -83.48 -48.46 10.27 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.289 -0.882 . . . . 0.75 110.682 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.79 -50.04 68.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.255 -0.978 . . . . 0.82999999999999996 109.123 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.8 t -70.06 -31.81 69.6 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 122.241 1.02 . . . . 0.78000000000000003 109.023 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.49 -49.79 74.69 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.416 -1.474 . . . . 0.56999999999999995 109.416 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH22 ' CD ' ' A' ' 86' ' ' GLU . 17.9 ttp180 -58.96 -27.03 64.96 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.187 -1.184 . . . . 2.8300000000000001 110.212 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -37.9 78.17 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.992 0.901 . . . . 0.65000000000000002 110.107 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -83.43 -49.67 9.07 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.634 -0.666 . . . . 2.5699999999999998 110.753 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -36.32 73.44 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.427 -0.909 . . . . 0.51000000000000001 109.848 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.8 t -62.12 -40.13 94.87 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.326 1.06 . . . . 1.3600000000000001 109.139 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.56 -39.16 74.12 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.636 -0.711 . . . . 0.59999999999999998 109.832 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -66.87 -61.72 1.81 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.943 . . . . 1.3600000000000001 110.393 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.47 -38.07 63.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 1.3799999999999999 110.243 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -58.18 -39.44 78.9 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 1.27 110.62 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.0 m -67.77 -47.77 68.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.075 -1.015 . . . . 0.59999999999999998 110.436 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.3 mt -55.6 -39.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.53000000000000003 110.438 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -45.61 -47.96 14.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.98999999999999999 111.341 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -70.15 -28.69 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.297 -0.877 . . . . 0.58999999999999997 110.407 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -69.13 -27.46 65.59 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 122.463 1.125 . . . . 1.8100000000000001 110.178 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.56 52.12 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.604 0.716 . . . . 0.47999999999999998 109.68 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.47 -30.42 24.66 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.977 -1.106 . . . . 0.57999999999999996 110.557 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.28 -19.3 31.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.06 -1.259 . . . . 1.3899999999999999 111.209 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -93.62 -46.79 7.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.914 -0.584 . . . . 0.81999999999999995 111.03 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -107.04 -24.98 11.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.329 -0.857 . . . . 0.98999999999999999 112.724 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.47 165.05 12.68 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.25 -0.906 . . . . 0.55000000000000004 112.06 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -54.72 -11.2 0.55 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.762 -0.846 . . . . 2.5899999999999999 112.734 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.68 -37.04 85.37 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.21 -0.931 . . . . 2.2000000000000002 111.335 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -89.97 -17.62 27.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.822 -1.174 . . . . 1.79 112.434 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.13 -32.63 73.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 1.54 110.452 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.83 -34.69 78.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.039 -1.038 . . . . 0.64000000000000001 110.814 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -70.81 -41.87 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.374 -0.93 . . . . 0.57999999999999996 110.078 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -75.13 -25.8 58.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 122.309 1.052 . . . . 0.62 109.957 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -67.16 -35.03 78.81 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.726 0.774 . . . . 1.23 109.95 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.82 -37.48 66.01 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.259 -1.136 . . . . 0.52000000000000002 110.259 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -58.82 -49.57 77.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -1.097 . . . . 1.29 110.547 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.3 mt -58.41 -36.41 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.55000000000000004 110.13 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 ttt -58.87 -41.66 87.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 1.8899999999999999 109.954 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.23 -53.39 58.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.53000000000000003 110.555 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.6 tp -56.36 -39.73 73.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.725 -0.61 . . . . 0.42999999999999999 110.697 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.9 8.89 18.51 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 1.24 112.426 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.99 120.07 11.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.863 -1.148 . . . . 1.3100000000000001 109.435 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -10.86 56.03 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.204 1.002 . . . . 1.3500000000000001 110.458 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -82.13 -53.2 6.28 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.656 0.741 . . . . 2.1600000000000001 109.857 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.01 -27.38 69.37 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.364 1.078 . . . . 0.59999999999999998 110.17 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' CD ' HH22 ' A' ' 47' ' ' ARG . 87.3 tt0 -67.24 -48.4 67.88 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.626 -0.671 . . . . 1.28 110.397 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.17 -31.04 72.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 1.28 110.312 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.23 -57.25 4.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.283 -0.886 . . . . 1.29 109.836 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.2 mt -48.6 -45.1 14.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.352 -0.939 . . . . 0.57999999999999996 110.614 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.8 mt -63.64 -42.69 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 0.78000000000000003 110.311 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.72 82.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.052 . . . . 0.85999999999999999 110.922 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.73 -39.89 91.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.04 -1.037 . . . . 0.79000000000000004 110.608 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.96 -43.45 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.70999999999999996 110.558 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -85.34 -28.76 25.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.048 . . . . 2.0499999999999998 112.271 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 95' ' ' ASP . 43.1 t0 -88.66 -33.11 17.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.004 . . . . 1.5900000000000001 111.497 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -113.76 11.31 18.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 1.8899999999999999 110.191 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.3 m80 44.55 48.84 8.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 118.902 -1.119 . . . . 1.3100000000000001 110.854 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.3 mtt -99.48 157.45 16.43 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.478 0.656 . . . . 1.28 110.142 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.6 p -73.31 170.57 14.76 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.584 0.707 . . . . 0.62 109.775 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -35.83 75.12 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.215 -0.928 . . . . 0.46999999999999997 110.004 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.69 -42.09 64.62 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.959 0.885 . . . . 2.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.17 35.18 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.476 0.655 . . . . 0.56000000000000005 110.682 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.11 -0.994 . . . . 0.47999999999999998 110.394 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.44 110.805 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.54 -38.23 90.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.968 -1.082 . . . . 1.4199999999999999 110.86 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -56.59 -55.45 33.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.064 -1.022 . . . . 1.26 111.525 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.42 -47.2 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.723 -0.791 . . . . 0.60999999999999999 109.972 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.6 mm -63.15 -22.71 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.522 -0.736 . . . . 0.64000000000000001 110.882 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.15 -41.57 90.23 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.25 -0.906 . . . . 2.2000000000000002 110.174 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -25.43 34.21 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.654 -1.26 . . . . 0.81999999999999995 112.95 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -68.26 -31.23 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.449 -1.618 . . . . 1.27 110.311 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -50.54 9.78 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.411 0.624 . . . . 0.91000000000000003 110.548 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -33.88 75.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.389 -0.819 . . . . 1.73 110.125 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.26 96.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.083 -1.011 . . . . 1.04 110.424 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.28 -23.25 66.36 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.932 -1.105 . . . . 1.03 110.418 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -72.38 -19.43 61.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.904 0.859 . . . . 1.95 110.911 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.32 -12.99 59.93 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 122.227 1.013 . . . . 1.71 110.539 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 123' ' ' LEU . 7.7 mt -85.35 142.05 29.59 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.75 -0.833 . . . . 1.26 108.75 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.51 47.54 1.02 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.338 -0.851 . . . . 2.8300000000000001 111.594 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -120.37 143.25 48.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.308 -0.87 . . . . 1.5800000000000001 109.319 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.21 -32.0 73.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.418 -0.801 . . . . 2.7999999999999998 110.676 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.74 -54.44 6.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 1.02 110.304 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 118' ' ' LEU . 18.6 mt -60.84 -36.73 79.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 110.179 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -65.37 -56.59 11.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 2.3900000000000001 109.64 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.3 -19.45 34.76 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 118.498 -1.281 . . . . 2.2000000000000002 110.401 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -72.28 -26.09 61.85 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 123.375 1.56 . . . . 2.0899999999999999 108.549 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.77 81.16 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.448 -1.251 . . . . 0.85999999999999999 109.141 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.83 -38.89 76.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.451 0.643 . . . . 0.90000000000000002 110.183 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -68.05 -28.79 67.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 1.3500000000000001 111.215 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.88 -39.62 52.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.725 -0.79 . . . . 0.57999999999999996 109.692 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -58.81 -37.36 76.21 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.976 -1.09 . . . . 3.2200000000000002 109.361 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -62.48 -32.65 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.78 -0.646 . . . . 1.3200000000000001 110.333 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -66.44 -43.13 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.5 110.524 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.52 -38.44 68.9 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.772 -1.204 . . . . 0.44 110.153 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -57.19 -43.48 82.71 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.505 -0.997 . . . . 2.71 109.69 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 140' ' ' ASN . 39.9 mtt-85 -63.68 -52.53 60.23 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.481 -0.888 . . . . 2.2000000000000002 109.642 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.9 tp -50.67 -40.0 52.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 120.121 -0.632 . . . . 1.1299999999999999 110.124 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.9 mt -60.95 -43.08 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 0.54000000000000004 110.306 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -66.29 -25.66 66.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.165 -0.959 . . . . 2.3199999999999998 111.558 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' ARG . 13.5 m120 -81.36 -32.54 32.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 1.26 110.86 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.91 -38.27 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.519 -0.872 . . . . 0.62 109.597 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.3 mt -89.24 -9.46 50.61 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.347 1.07 . . . . 0.67000000000000004 111.055 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.62 26.12 70.52 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.389 -1.386 . . . . 0.68000000000000005 112.668 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.89 146.22 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.846 -0.798 . . . . 0.77000000000000002 108.846 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.88 146.65 54.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.387 -0.821 . . . . 2.3999999999999999 109.934 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -105.09 138.94 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.111 -1.07 . . . . 0.87 108.111 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.744 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.1 mp -79.15 125.79 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.169 -0.957 . . . . 1.3200000000000001 108.975 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -95.91 94.19 7.47 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.711 -1.218 . . . . 1.54 107.711 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.03 -21.44 56.84 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.075 0.94 . . . . 0.77000000000000002 110.42 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.0 t -80.47 8.35 7.88 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.096 -1.003 . . . . 1.5700000000000001 111.491 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -105.76 25.15 11.18 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.481 0.658 . . . . 0.81999999999999995 111.392 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 153' ' ' GLN . 22.7 mt -73.61 157.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.393 -0.817 . . . . 0.81999999999999995 109.471 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.431 ' N ' HG22 ' A' ' 152' ' ' ILE . 70.2 mt-30 -131.72 -23.12 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 2.1099999999999999 111.269 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.97 133.04 54.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.545 -0.909 . . . . 1.4099999999999999 108.545 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.71 116.68 7.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 1.3 109.127 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.35 176.94 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.551 -0.718 . . . . 0.56999999999999995 109.096 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 mt -88.02 145.6 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.595 -0.691 . . . . 0.42999999999999999 109.213 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 19' ' ' LEU . 32.4 tp -98.17 123.81 42.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.244 -0.91 . . . . 0.56000000000000005 108.863 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.8 t -123.87 129.56 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.247 -1.019 . . . . 0.54000000000000004 108.247 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.25 150.74 16.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.62 108.998 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.75 -31.82 70.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.782 -1.199 . . . . 0.80000000000000004 109.561 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.17 151.18 1.01 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.85 -0.796 . . . . 2.3399999999999999 108.85 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.2 mt -120.64 139.43 53.02 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.308 -0.997 . . . . 0.65000000000000002 108.308 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.8 p -91.25 149.69 40.2 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.73999999999999999 109.016 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.48 -53.04 1.46 Allowed 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 122.087 1.858 . . . . 0.59999999999999998 112.92 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 m -50.93 -58.24 6.53 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.4 -0.92 . . . . 0.63 110.917 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.5 -39.81 67.92 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.494 -0.882 . . . . 1.25 110.261 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.1 p -70.71 -31.77 68.74 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.419 -0.801 . . . . 0.5 110.058 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.92 67.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.498 -0.751 . . . . 0.51000000000000001 111.009 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -103.18 -4.73 24.01 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.048 0.928 . . . . 1.1699999999999999 112.566 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 39.1 tp -58.05 151.94 17.61 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 120.014 -0.674 . . . . 0.60999999999999999 109.434 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 176' ' ' VAL . 1.4 m-20 -97.7 114.96 27.06 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 122.408 1.099 . . . . 2.1200000000000001 108.544 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.0 mt -78.69 -11.06 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 1.3400000000000001 110.891 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.03 -20.29 25.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.185 -0.947 . . . . 1.97 111.594 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -105.07 -12.47 16.13 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.659 1.219 . . . . 1.8999999999999999 111.251 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.465 HG12 ' H ' ' A' ' 178' ' ' GLY . 57.9 t -98.79 127.74 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.533 -0.914 . . . . 0.47999999999999998 108.533 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.0 tp -91.84 -7.34 49.66 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.643 1.211 . . . . 1.3899999999999999 111.525 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.59 171.54 38.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.38 109.68 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 1.1 m-85 -127.44 133.9 49.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.003 -1.11 . . . . 0.46000000000000002 108.003 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.569 HG22 HG21 ' A' ' 205' ' ' THR . 63.2 mt -137.99 104.19 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 107.307 -1.368 . . . . 0.58999999999999997 107.307 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 203' ' ' VAL . 81.8 p -126.6 173.79 9.18 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.915 -1.116 . . . . 0.67000000000000004 110.414 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -101.54 55.51 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.246 -0.65 . . . . 2.2400000000000002 109.246 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -100.9 154.37 18.72 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.345 -0.847 . . . . 1.1100000000000001 109.883 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . -50.46 -46.41 45.55 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.505 -1.331 . . . . 1.6299999999999999 110.111 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 105.52 -29.28 11.71 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 121.632 -0.922 . . . . 1.47 111.955 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 -59.14 -72.46 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.362 -1.335 . . . . 5.2400000000000002 109.962 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 72.4 p -104.57 42.29 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 2.9199999999999999 109.455 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.8 t -85.2 124.44 31.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 1.6000000000000001 108.788 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -57.2 -40.41 77.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.313 -0.867 . . . . 0.92000000000000004 109.752 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 40.1 p -54.51 -51.83 63.89 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.234 -0.986 . . . . 1.5900000000000001 110.574 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.3 t -48.57 -43.17 35.49 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 119.592 -0.843 . . . . 1.4199999999999999 110.79 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 4.2 mt -62.12 -28.7 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 119.342 -0.943 . . . . 1.4099999999999999 110.594 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 69.1 mtp -69.85 -44.22 70.32 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.684 1.23 . . . . 0.85999999999999999 109.361 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 198' ' ' GLU . . . -59.17 -40.91 87.09 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.156 -0.929 . . . . 0.58999999999999997 111.18 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -65.89 -45.52 81.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.76 -1.212 . . . . 3.0600000000000001 110.742 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.8 m -69.13 -36.73 77.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.232 -0.917 . . . . 0.72999999999999998 110.047 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.56 -7.11 45.07 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.782 1.277 . . . . 0.67000000000000004 111.676 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 194' ' ' ALA . 97.4 mt-10 52.41 6.52 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.601 0.963 . . . . 1.49 113.601 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.79 147.84 98.94 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.131 -0.981 . . . . 0.64000000000000001 108.976 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -56.64 140.3 89.98 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.873 1.715 . . . . 0.58999999999999997 110.348 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . . . -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.108 -1.437 . . . . 0.55000000000000004 109.813 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.0 mt -151.54 153.7 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.001 -1.111 . . . . 0.63 108.001 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.5 m -136.49 -31.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 112.201 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.96 44.84 2.65 Favored Glycine 0 N--CA 1.48 1.59 0 C-N-CA 119.704 -1.236 . . . . 0.87 110.823 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.569 HG21 HG22 ' A' ' 180' ' ' ILE . 63.6 p -69.46 -12.18 61.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 122.475 1.131 . . . . 0.89000000000000001 110.985 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.36 -94.53 0.48 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.829 -0.908 . . . . 0.93000000000000005 110.829 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -129.86 37.82 3.89 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.549 -0.971 . . . . 1.6000000000000001 112.114 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.89 -30.76 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.9 -1.125 . . . . 0.75 109.663 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.476 HG23 ' OD1' ' A' ' 182' ' ' ASP . 27.3 p -63.86 -15.58 59.29 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.694 0.759 . . . . 0.83999999999999997 111.343 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.89 10.23 38.42 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.027 0.917 . . . . 1.6100000000000001 111.191 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -137.81 4.38 2.55 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.813 0.816 . . . . 2.2999999999999998 111.938 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.01 153.09 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.715 0.769 . . . . 0.76000000000000001 109.975 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -118.71 168.09 11.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.136 -1.061 . . . . 2.0099999999999998 108.136 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 45.5 p-10 -70.56 150.89 45.63 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.583 -1.247 . . . . 2.1899999999999999 108.85 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 36.2 m-20 77.86 -5.46 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.372 0.878 . . . . 2.3999999999999999 113.372 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.43 142.72 47.71 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.101 -1.039 . . . . 1.99 108.805 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -88.45 114.26 24.88 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.996 -1.065 . . . . 1.3 108.465 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 38.8 mt -124.65 147.99 48.21 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.594 0.711 . . . . 0.53000000000000003 109.615 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.77 124.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 107.096 -1.446 . . . . 0.59999999999999998 107.096 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.0 tp -94.42 119.56 33.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.577 -1.268 . . . . 0.56999999999999995 107.577 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 223' ' ' VAL . 22.2 t0 -91.62 -36.04 13.88 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.671 1.224 . . . . 2.2200000000000002 111.54 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.8 17.54 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.872 0.844 . . . . 0.75 113.263 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 221' ' ' ASP . 27.4 t -111.71 -62.59 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.998 -1.112 . . . . 0.92000000000000004 107.998 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -93.58 16.76 12.98 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 123.403 1.573 . . . . 2.3599999999999999 108.879 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 53.53 62.0 2.85 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 118.74 -1.184 . . . . 1.4199999999999999 109.415 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -154.58 144.16 21.47 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.314 -0.954 . . . . 1.97 109.855 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.92 139.76 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.551 -0.907 . . . . 0.65000000000000002 108.551 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -102.91 131.22 49.99 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.657 -0.868 . . . . 0.96999999999999997 108.657 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.2 124.98 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.192 0.996 . . . . 0.67000000000000004 109.135 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.7 t30 53.87 54.93 12.29 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.211 -0.931 . . . . 1.45 112.74 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.21 148.62 50.16 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.814 2.342 . . . . 0.81999999999999995 111.184 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.4 p -74.86 150.66 39.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 1.6200000000000001 109.557 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -51.07 -40.75 59.08 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.297 -0.877 . . . . 2.6000000000000001 110.369 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -54.87 -36.63 65.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.368 -0.832 . . . . 3.0600000000000001 110.37 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.56 -42.07 48.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 122.102 0.953 . . . . 1.1399999999999999 108.886 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.98 -61.55 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 118.911 -1.116 . . . . 1.04 109.479 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -35.7 13.31 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.361 -0.936 . . . . 2.54 110.917 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -68.03 -36.92 80.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.061 -1.025 . . . . 2.6000000000000001 110.187 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 70.5 mtp -79.9 -37.01 35.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 1.23 110.896 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -58.26 -32.62 68.55 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.283 -0.967 . . . . 2.6699999999999999 110.202 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.9 -66.01 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.895 . . . . 1.6599999999999999 109.414 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.49 -56.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.981 -1.088 . . . . 2.2000000000000002 110.845 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -45.22 -61.38 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.369 -0.932 . . . . 3.0 110.923 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.0 -24.4 67.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.144 0.973 . . . . 1.76 110.033 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -66.79 -20.7 66.0 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.453 1.121 . . . . 2.7799999999999998 109.499 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.4 -47.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.336 1.065 . . . . 2.0600000000000001 108.55 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.19 75.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 122.335 1.064 . . . . 2.3999999999999999 108.608 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 t -74.44 -33.64 62.98 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.02 0.914 . . . . 2.8700000000000001 109.261 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -68.92 -26.31 65.02 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 122.637 1.208 . . . . 3.4100000000000001 109.301 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -74.16 -44.01 55.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.467 1.127 . . . . 3.8799999999999999 108.375 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.3 -17.71 64.34 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 123.605 1.669 . . . . 4.4299999999999997 108.993 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -73.89 -19.86 60.58 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-O 123.337 1.541 . . . . 5.4199999999999999 108.616 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.415 HD12 HD12 ' A' ' 256' ' ' LEU . 5.5 tp -70.79 -28.45 64.66 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.793 1.759 . . . . 6.0999999999999996 107.59 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.77 -11.08 60.64 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 113.595 -1.639 . . . . 7.3700000000000001 109.255 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 257' ' ' LYS . 16.1 mttp -93.94 -6.15 46.15 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.281 -1.327 . . . . 8.0099999999999998 110.994 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.415 HD12 HD12 ' A' ' 253' ' ' LEU . 3.1 mt -75.01 5.01 5.67 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-O 123.966 1.841 . . . . 9.0500000000000007 110.085 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 255' ' ' LYS . 10.2 mtpt -95.34 -23.43 17.19 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 112.7 -2.046 . . . . 10.56 109.795 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 258' ' ' ASP . 0.4 OUTLIER -90.76 1.56 56.78 Favored 'General case' 0 C--O 1.207 -1.155 0 CA-C-O 124.105 1.907 . . . . 11.32 109.58 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.568 ' HG2' HH11 ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 113.311 -1.768 . . . . 12.42 108.334 -179.577 . . . . . . . . 2 2 . 1 stop_ save_